Scientists find potential way to halt pancreatic cancer spread

May 21, 2014

Cancer Research UK scientists have shown how switching off a key protein in pancreatic cells slows the spread of the disease to other tissues, a key step which can mean patients have just weeks to live.

The study, published in this month's issue of Gastroenterology, provides some of the first insights into how elevated levels of the protein 'fascin' help cells penetrate the tightly packed cells lining the abdomen.

Pancreatic cancer is difficult to treat because patients don't usually have symptoms until the disease begins to spread. As a result survival remains low, with only around 4 per cent of patients living more than five years.

Study leader Dr Laura Machesky, from Cancer Research UK's Beatson Institute in Glasgow, said: "We know fascin is overactive in many cancers, but this is the first time we've been able to show that tumours lacking this protein are less able to develop and spread. What's more, we found patients with elevated fascin levels were more prone to the cancer coming back and tended to succumb to the disease more quickly.

"It's early days, but we think that developing drugs to block fascin could potentially help halt cancer spread in patients with pancreatic cancer, and other cancers with higher levels of this protein."

This video is not supported by your browser at this time.

The researchers studied human cancer samples and mice predisposed to get pancreatic cancer. They found that when fascin was absent, pancreatic cancer was less able to spread around the body. In mice, this delayed the onset of the disease and resulted in smaller tumours.

Eleanor Barrie, senior science information manager at Cancer Research UK, said: "This new discovery paves the way for new drugs that could potentially slow cancer spread, reducing the chances that cells left behind after surgery could go on to re-grow the cancer. Pancreatic cancer is notoriously difficult to treat - less than four per cent of patients survive for five years or more, a situation that has seen little improvement in recent decades. We've recently announced increased funding for research that will give like this with hard to treat cancers the hope of a much brighter future."

Explore further: Swedish test may boost pancreatic cancer survival rates

More information: Li A. et al, "Fascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes," Gastroenterology (2014), DOI: 10.1053/j.gastro.2014.01.046

Related Stories

'Achilles heel' of pancreatic cancer identified

May 1, 2014

A research team at Georgetown Lombardi Comprehensive Cancer Center reports that inhibiting a single protein completely shuts down growth of pancreatic cancer, a highly lethal disease with no effective therapy.

Bacteria in mouth may diagnose pancreatic cancer

May 18, 2014

Patients with pancreatic cancer have a different and distinct profile of specific bacteria in their saliva compared to healthy controls and even patients with other cancers or pancreatic diseases, according to research presented ...

Recommended for you

Breast cancer drug beats superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.